{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:12:56Z","timestamp":1790327576891,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.metabol.2015.12.015","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T12:20:34Z","timestamp":1452169234000},"page":"543-556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations"],"prefix":"10.1016","volume":"65","author":[{"given":"Eisaku","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Fujikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakatsu","family":"Sone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Taura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kusakabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Ebihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiminori","family":"Hosoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Asaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuya","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuwa","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2015.12.015_bb0005","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2015.123","article-title":"Congenital generalized lipodystrophies\u2014new insights into metabolic dysfunction","volume":"11","author":"Patni","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2015.12.015_bb0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng585","article-title":"Identification of the gene altered in Berardinelli\u2013Seip congenital lipodystrophy on chromosome 11q13","volume":"28","author":"Magre","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2015.12.015_bb0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng880","article-title":"AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34","volume":"31","author":"Agarwal","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2015.12.015_bb0020","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2007-1328","article-title":"Association of a homozygous nonsense caveolin-1 mutation with Berardinelli\u2013Seip congenital lipodystrophy","volume":"93","author":"Kim","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.12.015_bb0025","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1172\/JCI38660","article-title":"Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy","volume":"119","author":"Hayashi","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2015.12.015_bb0030","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1210\/jc.2003-030835","article-title":"Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes","volume":"88","author":"Simha","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.12.015_bb0035","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/jmg.39.10.722","article-title":"Genotype\u2013phenotype relationships in Berardinelli\u2013Seip congenital lipodystrophy","volume":"39","author":"Van Maldergem","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.metabol.2015.12.015_bb0040","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10545-005-0038-5","article-title":"Phenotypic heterogeneity in biochemical parameters correlates with mutations in AGPAT2 or Seipin genes among Berardinelli\u2013Seip congenital lipodystrophy patients","volume":"28","author":"Gomes","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.metabol.2015.12.015_bb0045","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2015.12.015_bb0050","first-page":"1391","article-title":"New advances in the treatment of generalized lipodystrophy: role of metreleptin","volume":"11","author":"Rodriguez","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.metabol.2015.12.015_bb0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.metabol.2014.07.017","article-title":"Leptin in congenital and HIV-associated lipodystrophy","volume":"64","author":"Tsoukas","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.12.015_bb0060","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.metabol.2014.07.014","article-title":"Leptin treatment: facts and expectations","volume":"64","author":"Paz-Filho","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.12.015_bb0065","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2015.12.015_bb0070","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.1158799","article-title":"Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons","volume":"321","author":"Dimos","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.metabol.2015.12.015_bb0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature07677","article-title":"Induced pluripotent stem cells from a spinal muscular atrophy patient","volume":"457","author":"Ebert","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2015.12.015_bb0080","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2015.12.015_bb0085","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.cell.2009.02.013","article-title":"Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors","volume":"136","author":"Soldner","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2015.12.015_bb0090","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.stem.2011.04.019","article-title":"Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs","volume":"8","author":"Liu","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.metabol.2015.12.015_bb0095","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature09005","article-title":"Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome","volume":"465","author":"Carvajal-Vergara","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2015.12.015_bb0100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature08129","article-title":"Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells","volume":"460","author":"Raya","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2015.12.015_bb0105","doi-asserted-by":"crossref","first-page":"15768","DOI":"10.1073\/pnas.0906894106","article-title":"Generation of pluripotent stem cells from patients with type 1 diabetes","volume":"106","author":"Maehr","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2015.12.015_bb0110","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00125-012-2508-2","article-title":"Induced pluripotent stem cells generated from diabetic patients with mitochondrial DNA A3243G mutation","volume":"55","author":"Fujikura","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2015.12.015_bb0115","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood-2012-03-417881","article-title":"Induced pluripotent stem cells from CINCA syndrome patients as a model for dissecting somatic mosaicism and drug discovery","volume":"120","author":"Tanaka","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.metabol.2015.12.015_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/9780470151808.sc04a02s9","article-title":"Generation and characterization of human induced pluripotent stem cells","author":"Ohnuki","year":"2009","journal-title":"Curr Protoc Stem Cell Biol"},{"key":"10.1016\/j.metabol.2015.12.015_bb0125","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/sj.gt.3301206","article-title":"Plat-E: an efficient and stable system for transient packaging of retroviruses","volume":"7","author":"Morita","year":"2000","journal-title":"Gene Ther"},{"key":"10.1016\/j.metabol.2015.12.015_bb0130","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0092-8674(90)90385-R","article-title":"The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain","volume":"62","author":"McMahon","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2015.12.015_bb0135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nbt1374","article-title":"Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts","volume":"26","author":"Nakagawa","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.metabol.2015.12.015_bb0140","doi-asserted-by":"crossref","DOI":"10.1089\/scd.2013.0113","article-title":"In vitro characterization and engraftment of adipocytes derived from human induced pluripotent stem cells and embryonic stem cells","author":"Noguchi","year":"2013","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.metabol.2015.12.015_bb0145","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S0967199406003807","article-title":"ATP content and maturational\/developmental ability of bovine oocytes with various cytoplasmic morphologies","volume":"14","author":"Nagano","year":"2006","journal-title":"Zygote"},{"key":"10.1016\/j.metabol.2015.12.015_bb0150","doi-asserted-by":"crossref","first-page":"e898","DOI":"10.1371\/journal.pone.0000898","article-title":"Evidence based selection of housekeeping genes","volume":"2","author":"de Jonge","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2015.12.015_bb0155","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transfectants with a novel eukaryotic vector","volume":"108","author":"Niwa","year":"1991","journal-title":"Gene"},{"key":"10.1016\/j.metabol.2015.12.015_bb0160","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1101\/gad.968802","article-title":"Differentiation of embryonic stem cells is induced by GATA factors","volume":"16","author":"Fujikura","year":"2002","journal-title":"Genes Dev"},{"key":"10.1016\/j.metabol.2015.12.015_bb0165","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nbt1318","article-title":"Characterization of human embryonic stem cell lines by the International Stem Cell Initiative","volume":"25","author":"Adewumi","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.metabol.2015.12.015_bb0170","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.metabol.2015.12.015_bb0175","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/BF03401776","article-title":"Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers","volume":"6","author":"Itskovitz-Eldor","year":"2000","journal-title":"Mol Med"},{"key":"10.1016\/j.metabol.2015.12.015_bb0180","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.febslet.2009.02.031","article-title":"Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells","volume":"583","author":"Taura","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1016\/j.metabol.2015.12.015_bb0185","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.biocel.2011.03.002","article-title":"Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity","volume":"43","author":"Vigouroux","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.metabol.2015.12.015_bb0190","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrm3699","article-title":"The biophysics and cell biology of lipid droplets","volume":"14","author":"Thiam","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.metabol.2015.12.015_bb0195","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1083\/jcb.201305142","article-title":"Acyl-CoA synthetase 3 promotes lipid droplet biogenesis in ER microdomains","volume":"203","author":"Kassan","year":"2013","journal-title":"J Cell Biol"},{"key":"10.1016\/j.metabol.2015.12.015_bb0200","doi-asserted-by":"crossref","first-page":"20890","DOI":"10.1073\/pnas.0704154104","article-title":"The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology","volume":"104","author":"Szymanski","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2015.12.015_bb0205","doi-asserted-by":"crossref","first-page":"10747","DOI":"10.1021\/bi1013003","article-title":"Seipin is a discrete homooligomer","volume":"49","author":"Binns","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.metabol.2015.12.015_bb0210","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.physbeh.2010.05.014","article-title":"Transplantation or removal of intra-abdominal adipose tissue prevents age-induced glucose insensitivity","volume":"101","author":"Foster","year":"2010","journal-title":"Physiol Behav"},{"key":"10.1016\/j.metabol.2015.12.015_bb0215","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.biochi.2009.01.011","article-title":"Seipin deficiency alters fatty acid Delta9 desaturation and lipid droplet formation in Berardinelli\u2013Seip congenital lipodystrophy","volume":"91","author":"Boutet","year":"2009","journal-title":"Biochimie"},{"key":"10.1016\/j.metabol.2015.12.015_bb0220","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1083\/jcb.200711136","article-title":"Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast","volume":"180","author":"Fei","year":"2008","journal-title":"J Cell Biol"},{"key":"10.1016\/j.metabol.2015.12.015_bb0225","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2337\/db08-0184","article-title":"The human lipodystrophy gene BSCL2\/seipin may be essential for normal adipocyte differentiation","volume":"57","author":"Payne","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2015.12.015_bb0230","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1210\/en.2009-0236","article-title":"The human lipodystrophy gene product Berardinelli\u2013Seip congenital lipodystrophy 2\/seipin plays a key role in adipocyte differentiation","volume":"150","author":"Chen","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2015.12.015_bb0235","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-013-2926-9","article-title":"Thiazolidinediones partially reverse the metabolic disturbances observed in Bscl2\/seipin-deficient mice","author":"Prieur","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2015.12.015_bb0240","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1128\/MCB.06465-11","article-title":"Berardinelli\u2013Seip congenital lipodystrophy 2\/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation","volume":"32","author":"Chen","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2015.12.015_bb0245","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(04)15489-5","article-title":"No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial","volume":"363","author":"Carr","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2015.12.015_bb0250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s15010-006-5022-y","article-title":"Evaluation of safety and efficacy of rosiglitazone in the treatment of HIV-associated lipodystrophy syndrome","volume":"34","author":"Feldt","year":"2006","journal-title":"Infection"},{"key":"10.1016\/j.metabol.2015.12.015_bb0255","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1310\/hct1101-39","article-title":"A meta-analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophy","volume":"11","author":"Raboud","year":"2010","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.metabol.2015.12.015_bb0260","doi-asserted-by":"crossref","first-page":"7856","DOI":"10.1073\/pnas.89.17.7856","article-title":"Isolation and characterization of a full-length cDNA coding for an adipose differentiation-related protein","volume":"89","author":"Jiang","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2015.12.015_bb0265","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.biochi.2004.12.010","article-title":"Role of PAT proteins in lipid metabolism","volume":"87","author":"Londos","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.metabol.2015.12.015_bb0270","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1093\/hmg\/ddr205","article-title":"Seipin ablation in mice results in severe generalized lipodystrophy","volume":"20","author":"Cui","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2015.12.015_bb0275","doi-asserted-by":"crossref","first-page":"E1493","DOI":"10.1210\/jc.2014-1353","article-title":"Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy","volume":"99","author":"Christensen","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.12.015_bb0280","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1210\/jc.2003-030485","article-title":"Mutations in Gng3lg and AGPAT2 in Berardinelli\u2013Seip congenital lipodystrophy and Brunzell syndrome: phenotype variability suggests important modifier effects","volume":"89","author":"Fu","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.12.015_bb0285","doi-asserted-by":"crossref","first-page":"7054","DOI":"10.1073\/pnas.1324025111","article-title":"Lack of testicular seipin causes teratozoospermia syndrome in men","volume":"111","author":"Jiang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2015.12.015_bb0290","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00421-010-1473-z","article-title":"A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors","volume":"110","author":"Sanada","year":"2010","journal-title":"Eur J Appl Physiol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516000032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516000032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:10:38Z","timestamp":1758427838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049516000032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0026049516000032"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2015.12.015","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2015.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}